Glenn Nedwin

About three years ago, (Second Genome) really started focusing on pharmaceuticals, but it has always been doing Microbiome analytics for companies, academics and government labs. We are building this massive microbiome database on correlation of bacteria to metadata, and then we make products from there.

WHO

  • Glenn Nedwin, CEO, Second Genome

WHERE

  • USA, San Fransisco

TAGS

  • Music